BACKGROUND AND PURPOSE: Neutrophil-mediated lung injury is an insidious feature in sepsis although the mechanisms regulating pulmonary recruitment of neutrophils remain elusive. Here, we investigated the role of P-selectin glycoprotein-ligand-1 (PSGL-1) in sepsis-induced neutrophil recruitment and tissue injury in the lung. EXPERIMENTAL APPROACH: Bronchoalveolar infiltration of neutrophils, levels of myeloperoxidase, oedema formation and CXC chemokines were determined 24 h after caecal ligation and puncture (CLP) in mice. Animals were pretreated with a control antibody, monoclonal antibodies directed against PSGL-1 and P-selectin as well as a platelet-depleting antibody directed against GP1balpha. KEY RESULTS: CLP caused pulmonary damage characterized by oedema formation, neutrophil infiltration and increased levels of CXC chemokines in the lung. Immunoneutralization of PSGL-1 or P-selectin reduced CLP-induced neutrophil recruitment in the bronchoalveolar space by more than 56% and lung myeloperoxidase activity by 62%. Notably, the inhibitory effect of the anti-PSGL-1 antibody on sepsis-induced neutrophil infiltration was also observed in platelet-depleted mice. Moreover, inhibition of PSGL-1 and P-selectin abolished CLP-induced oedema formation and tissue damage in the lung. CLP-induced formation of CXC chemokines was not changed in mice pretreated with the anti-PSGL-1 and anti-P-selectin antibodies. CONCLUSIONS AND IMPLICATIONS: These data demonstrate that PSGL-1 plays a key role in pulmonary infiltration of neutrophils as well as lung oedema associated with abdominal sepsis. Moreover, our findings suggest that PSGL-1-dependent neutrophil recruitment is independent of circulating platelets. Thus, these novel findings indicate that PSGL-1 may be a useful target to protect against sepsis-induced accumulation of neutrophils and tissue damage in the lung.
BACKGROUND AND PURPOSE: Neutrophil-mediated lung injury is an insidious feature in sepsis although the mechanisms regulating pulmonary recruitment of neutrophils remain elusive. Here, we investigated the role of P-selectin glycoprotein-ligand-1 (PSGL-1) in sepsis-induced neutrophil recruitment and tissue injury in the lung. EXPERIMENTAL APPROACH: Bronchoalveolar infiltration of neutrophils, levels of myeloperoxidase, oedema formation and CXC chemokines were determined 24 h after caecal ligation and puncture (CLP) in mice. Animals were pretreated with a control antibody, monoclonal antibodies directed against PSGL-1 and P-selectin as well as a platelet-depleting antibody directed against GP1balpha. KEY RESULTS:CLP caused pulmonary damage characterized by oedema formation, neutrophil infiltration and increased levels of CXC chemokines in the lung. Immunoneutralization of PSGL-1 or P-selectin reduced CLP-induced neutrophil recruitment in the bronchoalveolar space by more than 56% and lung myeloperoxidase activity by 62%. Notably, the inhibitory effect of the anti-PSGL-1 antibody on sepsis-induced neutrophil infiltration was also observed in platelet-depleted mice. Moreover, inhibition of PSGL-1 and P-selectin abolished CLP-induced oedema formation and tissue damage in the lung. CLP-induced formation of CXC chemokines was not changed in mice pretreated with the anti-PSGL-1 and anti-P-selectin antibodies. CONCLUSIONS AND IMPLICATIONS: These data demonstrate that PSGL-1 plays a key role in pulmonary infiltration of neutrophils as well as lung oedema associated with abdominal sepsis. Moreover, our findings suggest that PSGL-1-dependent neutrophil recruitment is independent of circulating platelets. Thus, these novel findings indicate that PSGL-1 may be a useful target to protect against sepsis-induced accumulation of neutrophils and tissue damage in the lung.
Authors: D Sako; X J Chang; K M Barone; G Vachino; H M White; G Shaw; G M Veldman; K M Bean; T J Ahern; B Furie Journal: Cell Date: 1993-12-17 Impact factor: 41.582
Authors: M T Borchers; J Crosby; S Farmer; J Sypek; T Ansay; N A Lee; J J Lee Journal: Am J Physiol Lung Cell Mol Physiol Date: 2001-04 Impact factor: 5.464
Authors: Luca Battistini; Laura Piccio; Barbara Rossi; Simona Bach; Simona Galgani; Claudio Gasperini; Linda Ottoboni; Donatella Ciabini; Maria D Caramia; Giorgio Bernardi; Carlo Laudanna; Elio Scarpini; Rodger P McEver; Eugene C Butcher; Giovanna Borsellino; Gabriela Constantin Journal: Blood Date: 2003-02-20 Impact factor: 22.113
Authors: Abhijit Chandra; Jiro Katahira; Frank C Schmalstieg; Kazunori Murakami; Perenlei Enkhbaatar; Robert A Cox; Hal K Hawkins; Lillian D Traber; David N Herndon; Daniel L Traber Journal: Clin Sci (Lond) Date: 2003-03 Impact factor: 6.124
Authors: J Yang; T Hirata; K Croce; G Merrill-Skoloff; B Tchernychev; E Williams; R Flaumenhaft; B C Furie; B Furie Journal: J Exp Med Date: 1999-12-20 Impact factor: 14.307
Authors: Kendra N Iskander; Florin L Craciun; David M Stepien; Elizabeth R Duffy; Jiyoun Kim; Rituparna Moitra; Louis J Vaickus; Marcin F Osuchowski; Daniel G Remick Journal: Crit Care Med Date: 2013-01 Impact factor: 7.598
Authors: Rebecca M Baron; Silvia Lopez-Guzman; Dario F Riascos; Alvaro A Macias; Matthew D Layne; Guiying Cheng; Cailin Harris; Su Wol Chung; Raymond Reeves; Ulrich H von Andrian; Mark A Perrella Journal: PLoS One Date: 2010-05-14 Impact factor: 3.240
Authors: J Roller; Y Wang; M Rahman; R Schramm; M W Laschke; M D Menger; B Jeppsson; H Thorlacius Journal: Inflamm Res Date: 2012-11-20 Impact factor: 4.575